4,6-dimethyl-N-(tetrahydrofuran-2-ylmethyl)-1,3-benzothiazol-2-amine, 95.0%, 500mg

Methyl 4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylate, 97%, 5g

2,2'-Bicinchoninic Acid>98.0%(HPLC)1g

(S)-2-Phenyl-2,3-dihydrobenzo[d]imidazo[2,1-b]thiazole, 95.0%, 1g

6-FLUORO-3-(1-METHYL-1,2,3,6-TETRAHYDRO-4-PYRIDINYL)-1H-INDOLE, 97.0%, 1g

4-(Morpholine-4-sulfonyl)-aniline, 95.0%, 5g

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole, 95%, 25g

1,3-Dihydro-2H-pyrrolo[2,3-b]pyridin-2-one, 95.0%, 10g

Methyl 5-bromothiazole-4-carboxylate, 97.0%, 500g

2-Bromo-3-chloro-5-hydroxypyridine, 95.0%, 1g

Carriage with dark field disc for Abbe condenser with opening for bScope. Needs condenser with orifice (BS.9102)

5-Iodo-2,4-dimethoxypyrimidine>98.0%(GC)5g

2-Chloro-6-fluoroquinazoline, 98%, 1g